EP1346032A2 - Procede de production d'hydrates de carbone - Google Patents

Procede de production d'hydrates de carbone

Info

Publication number
EP1346032A2
EP1346032A2 EP01989498A EP01989498A EP1346032A2 EP 1346032 A2 EP1346032 A2 EP 1346032A2 EP 01989498 A EP01989498 A EP 01989498A EP 01989498 A EP01989498 A EP 01989498A EP 1346032 A2 EP1346032 A2 EP 1346032A2
Authority
EP
European Patent Office
Prior art keywords
nucleic acid
acid molecule
immobilized
acid sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01989498A
Other languages
German (de)
English (en)
Inventor
Dirk Engels
Alireza Haji Begli
Markwart Kunz
Ralf Mattes
Mohammad Munir
Manfred Vogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suedzucker AG
Original Assignee
Suedzucker AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10106163A external-priority patent/DE10106163B4/de
Application filed by Suedzucker AG filed Critical Suedzucker AG
Publication of EP1346032A2 publication Critical patent/EP1346032A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • C12N15/8246—Non-starch polysaccharides, e.g. cellulose, fructans, levans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Definitions

  • the present invention relates to nucleic acids which encode modified polypeptides with fructosyltransferase activity, vectors containing this nucleic acid for expression of the modified fructosyltransferase in pro- or eukaryotic cells, host cells and / or transgenic plants containing these vectors, processes for the production of high molecular weight polyfruetanes predominantly ⁇ -1,2 bonds and a very low degree of branching, in particular of inulin, process for the preparation of fructooligosaccharides using the ' inulin produced according to the invention or using sucrose, and process for the preparation of difruetose dianhydrides using the provided inulin or using sucrose, and the warping of the inulin produced according to the invention for the production of inulin ethers and inulin esters and the use of fructooligosaccharides or hydrogenated fructooligosaccharis - The and difructose diarihydrides as a food
  • Low-molecular saccharides for example monosaccharides such as glucose, and oligosaccharides such as sucrose are used as substrates for biotechnological processes or in modified form as auxiliaries for different ones Industries.
  • monosaccharides such as glucose
  • oligosaccharides such as sucrose
  • larger amounts of glucose are used for chemical syntheses, for example sorbitol and glutamate, and for technical purposes, including alcoholic fermentation.
  • Sucrose the economically most important type of sugar, is mainly used for food and preservation, but can also be used for plastics, varnishes, for the synthesis of protein, amino acids, antibiotics etc. and as an additive for rigid PU foams.
  • Polysaccharides such as cellulose and starch, are used much more frequently in their native or modified form in industry.
  • Starch is not just the most important human food.
  • Starch obtained in the factory is also used in the paper industry, for example for the production of cardboard or as a paper aid, for example for gluing paper, in the textile industry, for example as a size or for finishing and weighing down new fabrics or as a stiffening agent for.
  • Laundry, and in pharmacy for example as an explosive and filler for tablets, as a lubricant and filler for powder, as a basis for ointments etc.
  • Cellulose is one of the most important raw materials for numerous branches of industry.
  • cellulose The largest quantities of cellulose are consumed by the paper and textile industry, for example the most common textile fabrics consist of more or less pure, natural or artificially converted cellulose. Increasing importance. acquire polysaccharides or polysaccharide derivatives also as an additive in the construction industry.
  • both cellulose and starch have serious disadvantages.
  • chemical cellulose derivatives that is to say products which are produced, for example, via esterification and / or etherification reactions, substitutions, oxidation or crosslinking reactions
  • the production of cellulose derivatives is therefore generally much more expensive than the production of starch derivatives.
  • starch derivatives is associated with the problem that starch is a heterogeneous compound consisting of the linear amylose and the highly branched amylopectin.
  • the polyfructans are polysaccharides in which mainly fructose units are linked to one another. Polyfructans differ in the way the fructose units are linked. For example, the fructose units of the most important polyfructan inulin are in furanoside form with a ⁇ -1,2 bond. In the case of the polyfructan Levan, the fructose units are linked via ⁇ -2,6 bonds.
  • Polyfructans are reserve carbohydrates that can be found in a number of monocotyledon and dicotyledon plants, for example composites, grasses and cereals, but also in algae and some gram-positive and gram-negative bacteria.
  • Inulin is a polyfructan with a predominantly linear structure, where fructose units are linked via ß-1,2 bonds and the chain is probably terminated by a non-reducing ⁇ -D-glucose unit.
  • Inulin is found alone or together with starch as a reserve carbohydrate in dahlia tubers, artichokes, Jerusalem artichoke tubers, chicory roots and in the cells of inula and other aster family (compositae), less often also in related plant families (Campanulaceae, Lobeliaceae).
  • the inulins from different types of plants differ essentially in their average degree of polymerization.
  • inulin from Jerusalem artichoke has an average degree of polymerization of 5-7
  • inulin from chicory has an average degree of polymerization of 10-12
  • inulin from artichokes one average degree of polymerization of about 25
  • inulins or derivatives produced therefrom are not suitable for use as polymeric surfactants, emulsifiers and plasticizers.
  • the use of inulin as a bulking agent or as a fat substitute is also known.
  • fructooligosaccharides It is also known to hydrolyze inulin to fructooligosaccharides and to use them as prebiotic food ingredients (Wang, X. and Gibson, G.R., J. Appl. Biochem., 75 (1993), 373-380).
  • a serious disadvantage of these fructooligosaccharides is their relatively high glucose content.
  • fructooligosaccharides made from Jerusalem artichoke inulin contain about 40 to 20% glucose
  • fructooligosaccharides made from chicory inulin contain about 8 to 10% glucose.
  • Such fructooligosaccharides are only suitable to a limited extent for the nutrition of diabetics.
  • Ftf fructosyltransferase
  • Microbial fructosyltransferases have been detected, for example, in Streptococcus, Bacillus, Pseudomonas, Xanthomonas, Acetobacter, Erwinia and Actinomyces strains.
  • the fructose residues are linked via a ⁇ -1,2 and / or ⁇ -2,6 bond.
  • microbial fructosyltransferases are either inulin sucrases or levan sucrases. While vegetable polyfructans have a relatively low molecular weight, with about 10 to 30 fructose units being linked per molecule, have microbial ones Polyfructans have a molecular weight of up to 10 6 to '10 8 , where more than 100,000 fructose units can be linked. Studies on polyfructan biosynthesis have also shown that biosynthesis is generally much easier in bacteria than in plants. For the reasons mentioned, there is a strong interest in using bacterial fructosyltransferases in particular for the production of polyfructans.
  • the inulin produced from sucrose with the S. mutans fructosyl transferase has a molar mass of 20-60 x 10 6 g / mol
  • inulin produced in this way has about 7% branching and is therefore
  • microorganism S. mutans is a human pathogenic germ, so that its use and multiplication on an industrial scale.
  • rod for enzyme production has great problems.
  • Methods for producing carbohydrate polymers, in particular polyfructanes, in transgenic plants using ftf genes encoding microbial fructosyltransferases, for example the fructosyltransferase gene from S. mutans, are also known.
  • PCT / ÜS89 / 02729 describes a process for the production of carbohydrate polymers, in particular dextran or polyfructose, in transgenic plants.
  • the use of levan sucrases or dextran sucrases from various microorganisms is proposed for the production of these plants.
  • PCT / EP93 / 02110 discloses a process for producing polyfructose-producing transgenic plants which contain the Isc gene for a levan sucrase from a gram-negative battery.
  • PCT / US94 / 12778 describes methods for the synthesis and accumulation of carbohydrate polymers in transgenic plants, using, among other things, a bacterial fructosyltransferase gene which encodes a levan sucrase.
  • PCT / NL93 / 00279 discloses the transformation of plants with chimeric genes which contain the sacB gene from Bacillus subtiles or the ftf gene from Streptococus mutans.
  • SacB gene encoding a levan sucrase
  • a modification of the 5 'untranslated region of the bacterial gene is recommended in order to increase the expression level in transformed plants.
  • fructosyltransferase gene from Streptococcus mutans no sequence modifications are described, so that the level of expression of the fructosyltransferase is comparatively very low.
  • PCT / NL95 / 00241 describes processes for the production of oligosaccharides in transgenic plants, using the fructosyltransferase gene from Streptococcus mutans (Shiroza and Kuramitsu, 1988). Other fructosyltransferase genes of plant origin have also been used.
  • the use of the oligosaccharides produced in transgenic plants is also described as a sugar substitute, as a food supplement and as a bifidogenic agent in foods and as a bifidogenic agent in animal feed.
  • the present invention is therefore based on the technical problem, methods and agents, in particular methods and agents based on the fructosyltransferase gene from Streptococcus mutans, for the production of high molecular weight polyfructanes, in particular inulin, with ⁇ -1,2 bonds and one to provide an essentially linear structure and a very low glucose content which enable simple and inexpensive production of the polyfructans in large quantities, the problems described above in the prior art, in particular the low expression of bacterial fructosyltransferase genes in heterologous host systems, be overcome.
  • the present invention solves this technical problem in particular by providing a modified fructosyltransferase gene from Streptococcus mutans with a nucleic acid sequence as shown in SEQ ID No. 1 or a nucleic acid sequence which encodes an amino acid sequence as shown in SEQ ID No. 2, which is a at the N-terminus and / or encoded polypeptide modified at the C-terminus with the activity of a fructosyltransferase, in particular wherein the polypeptide has at least one deletion at the N-terminal and / or at the C-terminal end.
  • the present invention provides a, preferably isolated and completely purified, nucleic acid molecule according to the main claim, which encodes a polypeptide with the activity of a fructosyltransferase (ftf) and which is in a nucleic acid sequence shown in SEQ ID No. 1 or in one of these Nucleic acid sequence encoding amino acid sequence given in SEQ ID No. 2 has at least one deletion selected from the group consisting of:
  • the signal sequence of the native fructosyltransferase gene is completely or partially removed from S. mutans, so that the encoded signal peptide of the native S. mutans fructosyltransferase is completely or partially removed.
  • the intracellular enzyme production thus obtained eliminates the growth disorders of heterologous host cells, such as, for example, Escherichia coli, which are attributable to the expression of the fructosyltransferase from S. mutans, and the enzyme can be obtained from these cells in high volume yields. '
  • the deleted in the 5 'region of the nucleic acid sequence of the ftf gene sequences are replaced with at least one Se ⁇ frequency range of another gene NEN gron-, which is preferably is in the other gene is the lacZ ⁇ gene. Also a 'such mutant causes an improved growth of heterologous host cells and high volume yields of the expressed protein.
  • vectors can therefore be produced which ensure high expression of a modified polypeptide with the activity of a fructosyltransferase in pro- and / or eukaryotic cells.
  • a particularly high volume yield of the expressed protein is achieved in bacterial host systems if the nucleic acid molecules or nucleic acid molecules according to the invention deleted at the 5 'end and / or at the 3' end, in which the 5 ' deleted sequences are replaced by a sequence region of another gene, into the expression cassette of the Escherichia coli vector pJOE2702 (Volff et al., Mol. Microbiol., 21 (1996), 1037-1047; Stumpp et al., Biospectrum , 1 (2000), 33-36) can be integrated.
  • This vector can be induced by L-rhamnose and is positively regulated.
  • the pro- and eukaryotic host cells produced according to the invention can be used in processes for the production of polyfructans with ⁇ -1, 2 bonds, with a protein with the activity of a fructosyltransferase being isolated from the cells after the cultivation and propagation of these host cells is and the isolated protein • - is used in vitro for treatment of a sucrose solution.
  • the enzymatically formed polyfructan can then be isolated from the reaction mixture and be cleaned up.
  • a polyfructan can be isolated directly from host cells which contain one of the nucleic acid molecules according to the invention or from a transgenic plant which contains one of the nucleic acid molecules according to the invention.
  • the polyfructan thus produced is preferably inulin with a degree of polymerization of> 100 and a degree of branching of ⁇ 8%, preferably ⁇ 3%.
  • the inulin produced according to the invention is used in further preferred embodiments of the invention for the production of fructooligosaccharides or difructose dianhydrides.
  • a preferred method for the production of fructooligosaccharides provides that the inulin produced according to the invention is treated with an endo-inulinase and the fructooligosaccharides produced are then isolated from the reaction mixture.
  • a sucrose solution is treated simultaneously with a fructosyl transferase according to the invention and an endo-inulinase and then the enzymatically generated fructooligosaccharides are isolated from the reaction mixture and purified.
  • inulin produced according to the invention is treated with an endo- inulinase and cells from Arthrobacter globiformis or Arthrobacter ureafaciens.
  • a sucrose solution is treated with a fructosyltransferase according to the invention and an endo-inulinase and cells from A. globiformis or A. ureafaciens, and then the difructose dianhydrides generated are isolated and purified from the reaction mixture.
  • a, preferably isolated and purified, nucleic acid molecule which is a bacterial fructosyltransferase (ftf) gene and which codes a ' polypeptide with the activity of a fructosyltransferase and is located at the 5' end and / or at the 3 '- End contains at least one deletion .
  • ftf bacterial fructosyltransferase
  • a bacterial fructosyltransferase gene or a nucleic acid molecule which encodes a bacterial polypeptide with the activity of a fructosyltransferase means the coding DNA sequence of a gene whose gene product is the activity of a sucrose: 2, 1- ß-D-fructosyltransferase (EC 2.4.1.9) and originally comes from a bacterium, preferably from Streptococcus mutans.
  • fructosyl transferase or " ⁇ -D-fructosyl transferase” means a polypeptide or a protein that catalyzes the synthesis of a high molecular weight, repeating fructose unit carbohydrate polymer. can sieren, with sucrose serving as the starting substrate for the further polymerization.
  • the repeating fructose units are linked to one another via ⁇ -1,2 bonds, so that the fructosyltransferase which catalyzes the synthesis of this product can also be referred to as inulin sucrase.
  • the synthesized, high molecular weight polymer consisting of repeating fructose units preferably has a linear structure, may contain a terminal glucose residue derived from a sucrose molecule and u - comprises at least two fructose residues.
  • this carbohydrate is referred to as polyfructan.
  • the synthesized polyfructan is preferably inulin.
  • the nucleic acid can be a DNA sequence, for example part of a genomic DNA sequence, or an RNA sequence, for example an RNA sequence or a part thereof.
  • the nucleic acid can be of natural origin, that is to say it can be isolated from, for example, Streptococcus mutans cells, or it can be of synthetic origin.
  • the nucleic acid molecule according to the invention has at least one deletion selected from the group consisting of a) nucleotides 4 to 222, b) nucleotides 1 to 104 and c) nucleotides 2254 to 2385.
  • Deletion mutations can also be created with the aid of certain endonucleases, for example using the enzyme BAL-31.
  • Such enzymes degrade the ends which were generated by restriction enzyme cleavage, but deletion mutagenesis can also be achieved using a mutated primer in a PCR reaction
  • the sequence of such a primer spans the area which is to be deleted, the primer binding to two areas of a target region which flank the area to be deleted, so that the area spanned by the primer is not detected during amplification and is therefore not amplified.
  • the deletions of the fructosyltransferase gene according to the invention preferably relate to the 5 'region. and the 3 'region of the native Streptococcus mutans fructosyltransferase gene.
  • a particularly preferred embodiment with a deletion in the 5 'region, which comprises nucleotides 4 to 222, is the nucleic acid molecule with the nucleic acid sequence shown in SEQ ID No. 3, which encodes a protein with the amino acid sequence shown in SEQ ID No. 4.
  • a signal sequence mediates the secretion of the enzyme from cytoplasm a, the signal sequence during the secretion process being signaled by a signal.
  • peptidase is cleaved.
  • Signal peptide-dependent protein export which occurs in a similar manner in gram-positive and gram-negative bacteria, is a complex energy-dependent process in which a large number of soluble and membrane-bound proteins are involved (Schatz and Beckwith, Annu.
  • the fructosyltransferase protein is to be overproduced - in a heterologous host organism, the signal sequence could impair the growth of the host and thus reduce the product yield if the signal sequence is also functional in the heterologous host and the amount of protein produced has the capacity of the secretion mechanism and / or if other physiological intra- or extracellular processes in the area of the cell membrane are disrupted by the recombinant protein itself or by the secretion of the recombinant protein.
  • a particularly preferred embodiment for a deletion in the 3 'region of the native fructosyltransfer ferase gene is the nucleic acid molecule with the nucleic acid sequence shown in SEQ ID No.
  • those in the 5 'region of the Fruc . tosyltransferase gene deleted sequences replaced by the sequence region of another gene.
  • the other gene is the lacZ ⁇ gene.
  • the term “replace” means that the ftf sequences coding for the signal peptide can be replaced in whole or in part by equivalent sequences of another gene. When using the lacZ ⁇ gene, equivalent sequences of this gene are therefore replaced with the at the
  • nucleic acid molecule having the nucleic acid sequence shown in SEQ ID No. 5, which encodes an amino acid sequence shown in SEQ ID No. 6.
  • nucleotides 1 to 104 of the native fructosyltransferase nucleic acid sequence were replaced by nucleotides 1 to 83 of the lacZ ⁇ gene.
  • the nucleic acid molecule therefore has a deletion of nucleotides 1 to 104 compared to the native ftf sequence.
  • the exchange at the 5 'end leads to the gene product being localized in the periplasmic space. Host cells transformed with such a plasmid therefore show significantly improved growth compared to the heterologous host cells containing the wild-type ftf gene, and the fusion protein can also be obtained in high volume yields.
  • nucleic acid molecule in SEQ ID NO. Nucleic acid molecule 9 shown encoding an amino acid sequence shown in ⁇ SEQ ID NO. 10, and the nucleic acid molecule in SEQ ID NO. Nucleic acid sequence shown 11, the one in SEQ ID NO: 12 encoded amino acid sequence shown.
  • the nucleic acid molecule with SEQ ID No. 9 has a deletion of nucleotides 4 to 222 at the 5 'end and a deletion of nucleotides 2254 to 2385 at the 3' end.
  • nucleotides 1 to 104 have been replaced by nucleotides 1 to 83 of the lacZ ⁇ gene and the 3 'end also has a deletion of nucleotides 2254 to 2385. Both ftf gene variants lead to the expression of the corresponding gene products heterologous host systems for a significant improvement in growth, the corresponding gene products can be obtained in high volume yields.
  • the invention also encompasses modified nucleic acid molecules which can be obtained, for example, by substitution, addition, inversion and / or deletion of one or more bases of a nucleic acid molecule according to the invention, that is to say also nucleic acid molecules which are mutants, derivatives and functional equivalents, ie structurally different but functionally identical or functionally similar modifications of a nucleic acid molecule according to the invention.
  • the sequence of nucleic acid molecules can, for example, be further modified in a targeted manner in order to generate suitable restriction sites within the nucleotide sequence or to remove unnecessary parts of the sequence.
  • the modifications of the nucleic acid molecules according to the invention can be carried out with the aid of standard methods of microbiology / molecular biology.
  • the corresponding nucleic acids are inserted into plasmids and subjected to mutagenesis methods or a sequence change by recombination.
  • mutagenesis methods or a sequence change by recombination.
  • Transitions or transversions are suitable, for example, methods for in vitro mutagenesis, "primer repair” methods and restriction and / or ligation methods (see Sambrook et al., 1989, Molecular Cloning: A Laboratory Manuel, 2nd edition (1989), Gold Spring Harber Laboratory, Cold Spring Harbor, NY, USA).
  • Further sequence changes Changes can also be achieved by adding natural or synthetic nucleic acid sequences.
  • the present invention further relates to vectors which contain the nucleic acid molecules according to the invention.
  • the vectors are preferably plasmids, cosmids, viruses, liposomes, bacteriophages, shuttle vectors and other vectors commonly used in genetic engineering.
  • the vectors according to the invention can contain further functional elements which bring about or at least contribute to stabilization and / or replication of the vector in a host cell.
  • the present invention environmentally vectors in which at least one inventive Nucleinklad- • kül under the functional control of at least one regulatory element is touched.
  • regulatory element is understood to mean those elements which ensure the transcription and / or translation of nucleic acid molecules in prokaryotic and / or eukaryotic host cells, so that a polypeptide or protein is expressed.
  • Regulatory elements can be promoters, enhancers, silencers and / or transcription termination signals.
  • Regulatory elements which are functionally linked to a nucleotide sequence according to the invention, in particular the protein-coding sections of this nucleotide sequence can be nucleotide sequences which originate from organisms or genes other than the protein sequence.
  • T7, T3, SP6 and other common regulatory elements for in vitro transcription are: T7, T3, SP6 and other common regulatory elements for in vitro transcription; P LAC / 'P Ltet and other common regulatory elements for expression in E. coli; GAL1-10, MET25, CUP1, ADH1, AFH1, GDH1, TEF1, PMA1 and other regulatory elements for expression in the baker's yeast S.
  • Tissue- or organ-specific - in particular storage organ-specific promoters such as the Vicillin promoter from Pisum sativum, the Arabidopsis promoter AtAAP1 or the patatin B33 promoter, for expression in plant systems.
  • the invention provides that the nucleic acid molecules according to the invention are fused to a signal sequence which encodes a signal peptide for inclusion in the endoplasmic reticulum of a plant cell and for transmission to the vacuole.
  • a signal sequence which encodes a signal peptide for inclusion in the endoplasmic reticulum of a plant cell and for transmission to the vacuole.
  • Vacuolar localization of the gene products is particularly advantageous.
  • signal peptides can be used for the vacuolar localization of lectin from barley, signal sequences from a patatin gene of the potato or signal sequences from ripe phytohemoglutin in the bean.
  • the regulatory elements derive from the L-rhamnose operon from Escherichia .coli.
  • a nucleic acid molecule according to the invention is inserted into the express sionskassette of the vector pJOE2702 (Volff et al., 1996; Stumpp et al., 2000) integrated.
  • the expression cassette comprises the promoter rha P , which comes from the two-stage regulated L-rhamnose operon rhaBAD from Escherichia coli (Egan and Schleif, J. Mol. Biol., 243 (1994), 821-829).
  • the vector pJOE2702 is therefore an L-rhamnose-inducible expression vector which can be positively regulated over two stages and which is present in high numbers in the host bacterium Escherichia coli.
  • the transcription termination and the translation initiation of the transcripts also take place via sequences of the expression cassette contained in the vector.
  • pJOE2702 has two decisive advantages. First, the vector in the non-induced state leads to a very low base expression of the polypeptide to be expressed. Second, transcription of the expression cassette is induced with a delay.
  • the vector is therefore particularly suitable for cloning and producing proteins which have a negative influence on the vitality and the growth properties of the host cell, such as, for example, bacterial fructosyltransferases.
  • Escherichia coli cells which contain the vector pJOE2702 with the complete S. utans fructosyltransferase gene show complete growth inhibition after induction
  • the vector is particularly suitable for expression of the nucleic acid molecules according to the invention, End and at the 3 'end contain at least one of the deletions according to the invention.
  • the present invention naturally also includes vectors which contain not only one but several of the nucleic acid molecules according to the invention.
  • nucleotide sequences can be arranged such that one, two or more of the nucleotide sequences according to the invention, in particular the one shown in SEQ ID No. 3, SEQ ID No. 5, SEQ ID No. 7, SEQ ID No. 9 or SEQ ID No. 11 sequences described, can be controlled by a single set of regulatory elements.
  • the present invention relates to host cells which comprise one or more of the nucleic acid molecules according to the invention or one or more of the vectors according to the invention and which are capable of expressing the polypeptides encoded by the nucleic acid molecules with the activity of a fructosyl transferase
  • the hosts of the invention can be either 'prokaryotic and to eukary- ontological cells.
  • Preferred examples of prokaryotic cells are bacteria such as Escherichia coli or Bacillus subtilis.
  • Examples of eukaryotic host cells preferred according to the invention include yeast cells, insect cells and plant cells.
  • the host cell according to the invention can be characterized in that the introduced nucleotide sequence according to the invention is heterologous with respect to the transformed cell, that is to say that the introduced nucleotide sequence according to the invention does not naturally occur in these cells' or else at another location in these cells or else in another copy number or orientation in the genome of these cells locally is the corresponding naturally occurring sequence.
  • the host cell is a gram-negative cell, in particular an Escherichia coli cell. In a further advantageous embodiment, however, it can also be a gram-positive cell, for example a Bacillus subtilis cell.
  • the host cell according to the invention is a eukaryotic host cell.
  • the host cell according to the invention can be a yeast cell, for example a Saccharo yces cerevisiae cell.
  • Other preferred cells are insect cells, for example the IPLB-Sf21 insect cell line.
  • the host cell is a plant cell, in particular a cell of those plants which naturally produce polyfructans, in particular inulin, such as, for example, a Jerusalem artichoke, artichoke or chicory cell, or cells of agriculturally important plants, which naturally produce other monosaccharides, oligosaccharides and / or polysaccharides, such as a potato, cassava or sugar beet cell.
  • a plant cell in particular a cell of those plants which naturally produce polyfructans, in particular inulin, such as, for example, a Jerusalem artichoke, artichoke or chicory cell, or cells of agriculturally important plants, which naturally produce other monosaccharides, oligosaccharides and / or polysaccharides, such as a potato, cassava or sugar beet cell.
  • the invention also relates to cell cultures which have at least one of the host cells according to the invention, wherein a cell line according to the invention has the ability to co-use a polypeptide or protein the activity of a fructosyltransferase or to produce a fragment thereof.
  • the invention also relates to plants which contain at least one nucleic acid molecule according to the invention or at least one vector according to the invention in at least one of their cells or which contain at least one, but preferably a multiplicity, of host cells which contain the fructosyltransferase gene according to the invention or vectors or plasmids containing this have, and which can consequently produce high molecular weight polyfructans, especially high molecular weight inulin.
  • the invention thus also makes it possible to provide plants of the most diverse types, genera, families, orders and classes which, owing to the nucleic acid molecules according to the invention, are capable of producing high molecular weight inulin.
  • the inulin produced in these transgenic plants has a higher molecular weight than naturally formed plant inulin. While naturally produced vegetable inulin has an average of 10 to 30 fructose units per molecule, the polyfructan formed in transgenic plants can have more than 100,000 fructose units.
  • the invention also relates to a transgenic harvesting and propagation material of the plant containing a nucleic acid molecule according to the invention and parts or calli of a plant according to the invention, for example storage organs, fruits, tubers, beets, seeds, leaves, flowers or the like.
  • the plant to be transformed is either a plant which can naturally produce a polyfructan, in particular inulin, preferably a Jerusalem artichoke, artichoke or chicory plant, or an agriculturally important useful plant which naturally contains monosaccharides, oligosaccharides or can produce polysaccharides, preferably a potato, cassava or sugar beet plant.
  • the invention also relates to methods for producing the aforementioned plants, comprising the transformation of one or more plant cells with a vector of the invention, the integration of the nucleic acid molecule contained in this vector into the genome of the plant cell (s) and the regeneration of the plant cell (s) intact , transformed plants that can produce a high molecular weight polyfructan, especially inulin.
  • the invention also relates to a modified polypeptide or protein with the activity of a fructosyltransferase, which can catalyze the conversion of sucrose into a ' polyfructan, in particular .Inulin, with furanoside ⁇ -1,2-bonds.
  • the present invention relates in particular to a preferably isolated and fully cleaned nigt, protein which can be obtained by expression of a nucleic acid molecule according to the invention or a fragment thereof in a host cell according to the invention or a plant according to the invention and which has the aforementioned biological activity.
  • the protein preferably has the same properties, in particular the same activity of a fructosyltransferase as the protein which is encoded by a nucleic acid molecule with the nucleotide sequence shown in SEQ ID No. 1 and whose amino acid sequence is shown in SEQ ID No. 2.
  • the present invention also encompasses isolated and completely purified monoclonal or polyclonal antibodies or fragments thereof, which react with a polypeptide or protein according to the invention so specifically and with such an affinity that, using these monoclonal or polycyclonal antibodies or their fragments, more commonly with the aid immunological methods, for example a detection of a protein according to the invention is possible.
  • a preferred embodiment of the invention therefore comprises monoclonal and polyclonal antibodies which can specifically identify and / or bind to a structure of a polypeptide or protein according to the invention with the activity of a fructosyltransferase.
  • a structure may be a protein, peptide, carbohydrate, proteoglycan and / or act a lipid complex, which / who is a part of the protein of the invention or is with this ⁇ in specific relation ship.
  • the invention also encompasses antibodies directed against structures that nis post-translational modifications of the protein according to the invention have arisen.
  • the invention also includes fragments of such antibodies, such as Fc or F (ab ') 2 or Fab fragments.
  • the present invention further relates to antibodies which are directed against an antibody according to the invention, that is to say can identify and bind to an antibody according to the invention, so that specific detection of the antibodies according to the invention is possible.
  • the present invention further relates to processes for the production of longer-chain polyfructanes with a linear structure, the fructose units in the chain being linked by ⁇ -1,2 bonds, and with a degree of polymerization of more than 100 and a degree of branching of less than 3%.
  • the polyfructan is isolated and purified from transgenic plants transformed according to the invention, in particular from their vacuoles. Isolation and recovery of polyfructans from the storage organs of potato, Jerusalem artichoke, artichoke, chicory, cassava or sugar beet plants is particularly preferred.
  • the method comprises the mechanical comminution of larger plant cell masses with the aid of a turbine mixer, for example a waring blender, the comminution preferably taking place in a large volume of aqueous medium at low temperatures, for example + 4 ° C.
  • Further digestion can be carried out using physical digestion processes, for example by means of ultrasound, a “French press” device, mills or presses, with the aid of chemical digestion processes, for example lyophilization or with the use of detergents or with the use of osmotic pressure changes, or with the aid of biological digestion processes, for example using attacking the cell wall Enzymes or by means of an acid / alkali treatment
  • the high molecular weight polyfructan is obtained by producing an aqueous extract, in particular the storage organs, and subsequent precipitation with alcohol.
  • a further advantageous embodiment of the process for the production of polyfructanes provides that host cells according to the invention, for example plant host cells or microbial host cells, for example Escherichia coli cells, are cultivated and propagated in a suitable nutrient medium and under suitable culture conditions.
  • the cell material produced is then disrupted using suitable physical, chemical and / or enzymatic processes and the proteins with the activity of a fructosyltransferase are purified from the disruption.
  • the further purification of the enzymatic activity takes place with the aid of conventional methods known in the art.
  • the digestion solution is treated, for example, with the aid of extraction processes, centrifugation processes and filtration processes.
  • the precipitation of the proteins from the crude extract and ultrafiltration processes are efficient efficient process for concentrating proteins from a large amount of liquid.
  • Inorganic salts for example sodium and ammonium sulfate
  • organic solvents for example alcohols
  • polymers for example polyethylene glycol
  • a dialysis process can then be carried out to remove the precipitants used.
  • a further fine cleaning can be carried out with the aid of chromatographic processes and distribution processes, for example using aqueous phase systems. These methods include adsorption chromatography, ion exchange chromatography, gel chromatography and affinity chromatography.
  • the isolated fructosyltransferase can also be immobilized by means of adsorption on an inert or on an electrically charged, inorganic or organic carrier material.
  • Inorganic materials such as porous glasses, silica gel, aluminum oxide, hydroxylapatite or various metal oxides, natural polymers, for example cellulose, starch, alginates, agarose or collagen, or synthetic polymers, such as polyacrylamide, polyvinyl alcohol, methyl, are used as the carrier material. Acrylate, nylon or oxirane for use.
  • the immobilization takes place through physical binding forces such as Van der Waals forces, hydrophobic interactions and ionic bonds.
  • the fructosyl erase can also be immobilized by means of covalent binding to carrier materials.
  • the carriers must have reactive groups with amino acid side chains can form homeopolar bonds. Suitable groups are, for example, carboxy, hydroxyl and sulfide groups.
  • the surface of porous glasses can be activated, for example, by treatment with silanes and then reacted with proteins. Hydroxy groups of natural polymers can be activated with cyanogen bromide and carboxy groups with thionyl chloride and then coupled with enzymes.
  • Another possibility of immobilizing fructosyltransferases is to include them in three-dimensional networks. One advantage of this is that the enzymes are available in free, unbound form within the network. The pores in the surrounding matrix must be small enough to retain the enzyme.
  • a sucrose solution is treated with the isolated enzyme under suitable conditions, a polyfructan being formed in vitro.
  • suitable conditions include a suitable temperature, preferably 30 ° C., a suitable pH value, a suitable buffer and suitable substrate concentrations.
  • the polyfructan formed is then isolated from the reaction mixture and purified.
  • the invention also relates to the high-molecular polyfructan produced with the aid of the aforementioned methods.
  • the polyfructan thus produced is characterized by a predominantly linear structure, with fructose- Units are linked by ⁇ -1, 2 bonds and the chain ends with a non-reducing ⁇ -D-glucose unit.
  • the polyfructan is characterized by a very high degree of polymerization of> 100 and a very low degree of branching of ⁇ 3%. Due to the low branching, the polyfructan produced in this way contains very few terminal glucose units.
  • the polyfructan is preferably inulin, which is characterized by a high molecular weight of more than 1.5 million daltons.
  • the polyfructan produced according to the invention in particular inulin, can be used to produce fructooligosaccharides which are suitable as a dietary food.
  • a preferred embodiment of the invention therefore also relates to processes for the preparation of fructooligosaccharides.
  • the inulin produced according to the invention is treated under suitable conditions with an immobilized or non-imilized, suitable endo-inulinase and then the fructooligosaccharides produced are isolated from the reaction mixture and purified.
  • an “endo-inulinase” is understood to mean a 2, 1- ⁇ -D-fructan-fructan hydrolase which catalyzes the breakdown of inulin to fructooligosaccharides, the enzymatic action in particular. takes place within the polymer chain.
  • fructooligosaccharides is understood to mean saccharides which consist of 2 to 10 fructose units which are linked to one another in a ⁇ -glycosidic manner.
  • the endo-inulinase used can be in immobilized or non-immobilized form.
  • the immobilization of the endo-inulinase can take place as described above for the fructosyl transferase according to the invention.
  • Suitable conditions include a suitable temperature, preferably 30 ° C, a suitable pH, a suitable buffer and suitable substrate concentrations.
  • a sucrose solution is treated in vitro under suitable conditions simultaneously with an immobilized or non-immobilized fructosyl transferase produced according to the invention and an immobilized or non-immobilized endo-inulinase and then the generated fructooligosaccharides are isolated from the in vitro reaction mixture and purified.
  • the invention therefore also relates to fructooligosaccharides which have been prepared by one of the processes mentioned above.
  • the fructooligosaccharides produced with the aid of the method according to the invention are distinguished in particular by a very low glucose content and are therefore particularly suitable as a dietary food, in particular for diabetics. While fructooligosaccharides made from Jerusalem artichoke inulin had a glucose content of about 14 have up to 20% and fructooligosaccharides made from chicory inulin contain about 10% glucose, the fructooligosaccharides made according to the invention have less than 3% glucose, preferably less than 1%.
  • the fructooligosaccharides produced according to the invention can also be subjected to hydrogenation, hydrogenated fructooligosaccharides being produced, which are also particularly suitable as a dietary food.
  • the hydrogenation of the fructooligosaccharides produced according to the invention can be carried out, for example, using higher pressures and using catalysts.
  • the present invention relates to processes for the preparation of difructose dianhydrides.
  • Difructose dianhydrides are of particular interest as a food additive because they are non-digestible in the small intestine and have a pronounced prebiotic effect in the large intestine and thus contribute sustainably to a healthy intestinal flora and wall.
  • inulin produced according to the invention under suitable conditions simultaneously with an immobilized or non-immobilized .
  • Endo-inulinase and immobilized or non-immobilized cells of Arthrobacter globiformis or Arthrobacter ureafaciens is treated.
  • the endo-inulinase catalyzes as described above led to the conversion of inulin to fructooligosaccharides.
  • These are then converted by the inulin fructotransferase from A. globiformis or A. ureafaciens (Seki et al., Starch / Starke, 40 (1988), 440-442).
  • ureafaciens are in immobilized form.
  • cultured inactivated cells can be used directly as biocatalysts after suitable copolymerization, for example with the addition of a neutral protein and crosslinking with glutardialdehyde.
  • microorganisms in the form of photocrosslinked polymers, a microorganism suspension with the soluble prepolymers being polymerized in a thin layer by irradiation with, for example, a daylight lamp.
  • Suitable conditions for the preparation of difructosedian hydrides include a suitable temperature, preferably 30 ° C., a suitable pH, a suitable buffer and suitable substrate concentrations.
  • Another preferred embodiment of the process for the preparation of difructose dianhydrides provides that a sucrose solution is used simultaneously is treated with an immobilized or non-immobilized fructosyl transferase according to the invention, an immobilized or non-immobilized endo-inulinase and immobilized or non-immobilized cells of Arthrobacter globiformis or Arthrobacter ureafaciens, and the difructosedian hydrides generated are then isolated and purified from the reaction mixture.
  • the use of the inulin produced according to the invention is provided in various non-food applications.
  • the inulin produced according to the invention is subjected to corresponding derivatization reactions, inulin ethers and inulin esters being produced.
  • the inulin ethers and inulin esters thus produced can be used, for example, as polymeric surfactants, plasticizers or emulsifiers.
  • the present invention further provides for the use of the fructooligosaccharides produced according to the invention, the hydrogenated fructooligosaccharides produced according to the invention and the difructose dianhydrides produced according to the invention as a food additive, dietary food and as an animal feed additive.
  • FIG. 1 shows a restriction map of the plasmid pDHEH3, which contains the complete fructosyltransferase (ftf) gene from Streptococcus mutans DSM20523 with the nucleic acid sequence shown in SEQ ID No. 1 in the L-rhamnose-inducible Escherichia coli expression vector pJOE2702.
  • FIG. 2 shows a restriction map of the plasmid pDHE225 that the modified fructosyltransferase gene from Streptococcus mutans DSM20523 ftf ( ⁇ 4-> 222) with the nucleic acid sequence shown in SEQ ID No. 3, which is shortened by 219 nucleotides at the 5 'end , contains in the expression vector pJOE2702.
  • FIG. 3 shows a restriction map of the plasmid pDH171 that the fusion gene lacZ ⁇ (1--83):: ftf (105 ⁇ 2388) with the in SEQ ID NO. 5 contains the nucleic acid sequence shown in the expression vector pJOE2702, the fusion gene comprising 83 nucleotides of the lacZ ⁇ gene from the vector pBluescript II KS + and a modified fructosyltransferase gene from Streptococcus mutans DSM20523, shortened by 104 nucleotides at the 5 'end.
  • FIG. 4 shows a restriction map of the plasmid pDH132 that the modified fructosyltransferase gene from Streptococcus mutans DSM20523 ftf ( ⁇ 2254- »2385) with the nucleic acid sequence shown in SEQ ID No. 7 in the expression vector pJOE2702, where • the fructosyltransferase gene contains a del54osyltransferase gene ' to 2385.
  • FIG. 5 shows a restriction map of the plasmid pDHE172 that the modified fructosyltransferase gene ftf ( ⁇ 4- »222, ⁇ 2254-» 2385) with the nucleic acid sequence shown in SEQ ID No. 9 in the expression vector pJOE2702 contains, the fructosyltransferase gene 4 deleting the nucleotides to 222 and nucleotides 2254 to 2385.
  • FIG. 6 shows a restriction map of the plasmid pDHE143 that the fusion gene lacZ ⁇ (1--83):: ftf (105- »2388, ⁇ 2254-» 2385) with the nucleic acid sequence shown in SEQ ID No. 11 in the expression vector pJOE2702, the Fructosyl transferase gene has a deletion of nucleotides 1 to 104 and nucleotides 2254 to 2385 and the deleted 5 'region is fused to 83 nucleotides of the lacZ ⁇ gene.
  • SEQ ID No. 1 shows the 2388 nucleotide DNA sequence of the ftf gene from Streptococcus mutans DSM20523.
  • SEQ ID No. 2 shows the amino acid sequence comprising 795 amino acids derived from SEQ ID No. 1 of the fructosyltransferase protein according to the invention.
  • SEQ ID No. 3 shows the 2169 nucleotide DNA sequence of the modified fructosyltransferase gene ftf ( ⁇ 4-> 222).
  • SEQ ID No. 4 shows the 722 amino acid sequence, derived from SEQ ID No. 3, of a modified fructosyltransferase protein.
  • SEQ ID No. 5 shows the 2367 nucleotide DNA sequence of the fusion gene lacZ ⁇ (1--83) :: ftf (105- »2388).
  • SEQ ID No. 6 shows the amino acid sequence of 788 amino acids derived from SEQ ID No. 5 of a fusion protein according to the invention.
  • SEQ ID No. 7 shows the 2256 nucleotide DNA sequence of the modified fructosyltransferase gene. ftf ( ⁇ 2254- »2385).
  • SEQ ID No. 8 shows the amino acid sequence comprising 751 amino acids derived from SEQ ID No. 7 of a fructosyltransferase protein modified according to the invention.
  • SEQ ID No. 9 shows the 2037 nucleotide DNA sequence of the modified fructosyltransferase gene ftf according to the invention ( ⁇ 4- »222, ⁇ 2254-» 2385).
  • SEQ ID No. 10 shows the amino acid sequence comprising 678 amino acids derived from SEQ ID No. 9 of a fructosyltransferase protein modified according to the invention.
  • SEQ ID No. 11 shows the 2235th nucleotide DNA sequence of the fusion gene lacZ ⁇ (I- »83): ftf (105-» 2388, ⁇ 2254- »2385).
  • SEQ ID No. 12 shows the amino acid sequence of a fusion protein according to the invention, comprising 744 amino acids and derived from SEQ ID No. 11.
  • SEQ ID No. 13 shows the sequence of the primer ftf1 (upper).
  • SEQ ID No. 14 shows the sequence of the primer ftf2 (lower).
  • SEQ ID No. 15 shows the sequence of the primer ftf3 (upper).
  • SEQ ID No. 16 shows the sequence of the primer ftf4 (upper). ⁇
  • SEQ ID No. 17 shows the sequence of the primer ftf5 (upper).
  • SEQ ID No. 18 shows the sequence of the primer ftf6 (lower).
  • mutans DSM20523 which was isolated using a commercially available purification kit, served as a template in the PCR reaction.
  • the PCR reaction was carried out in 40 ⁇ l reaction volume, each with 8 pmol primer, 50 ng DNA template and 2.5 units of polymer polymerase in 10 mM Tris-HCl, pH 8.85, 25 mM KC1, 5 mM (NH 4 ) SO 4 , 2 mM MgSO 4 , 5% dimethyl sulfoxide, 0.2 mM dATP, 0.2 mM dTTP, 0.2 mM dGTP and 0.2 mM dCTP.
  • the PCR reaction u carried out the following steps: 5-minute denaturation at 96 ° C, 5 cycles, each comprising a 1-minute denaturation at 63 ° C, a 30-second primer addition at 40 ° C and a 2 minutes, 30 Polymerization lasting for seconds at 68 ° C, 25 further cycles, each comprising a 1 minute, 30 second denaturation at 92 ° C, a 1 minute, 30 second primer addition at 49 ° C and a 2 minute, 30 second polymerization , 68 ° C, and a 5-minute final polymerization reaction at 68 ° C. An approximately -2.4 kb fragment was amplified using the PCR reaction.
  • the isolated fragment was digested with the Ndel- and BamHI restrictases and with the vector pJOE2702 (Volff et al., Mol. Microbiol., 21 (1996) 1037-1047; Stumpp et al., Biospectrum, 1 (2000) 33- 36) which had been cleaved with the same restrictases.
  • the coding sequence of the ftf gene was thus inserted in the correct reading frame into the L-rhamnose contained in the vector.
  • inducible expression cassette cloned so that the transcription of the inserted nucleic acid is under the control of the promoter rha P contained in the vector pJOE2702.
  • the transcription termination of the ftf gene and the translation initiation of the transcripts also take place via sequences of the vector.
  • the E. coli strain JM109 was then transformed with the plasmid pDHEH3 resulting from the ligation. Transformants were selected via ampicillin resistance.
  • deletions were introduced or sequence regions were exchanged at the 5 'OH end of the ftf gene.
  • a PCR reaction was carried out with the primer ftf3 (upper) with the sequence: 5'-TATATATCATATGGAAACTCCATCAACAAATCCCG-3 'and the primer ftf2 (lower).
  • the primer ftf3 (upper) contains an Ndel interface.
  • the PCR reaction was ng in 40 ul reaction volume with 8 pmol primer, 100 '- plasmid DNA Te' mplate and 2.5 units of Pwo polymerase in 10 mM Tris-HCl, pH 8.85, 25 mM KC1, 5 mM (NH 4 ) SO 4 , 2 mM MgSO 4 , 0.2 mM dATP, 0.2 mM dTTP, 0.2 mM dGTP and 0.2 mM dCTP.
  • the PCR reaction comprised the following steps: a 2-minute denaturation at 94 ° C, 25 cycles, each comprising a 1-minute denaturation at 93 ° C, a primer attachment for 1 minute 30 seconds at 55 ° C and a polymerization for 2 minutes 20 seconds at 68 ° C, and a 5 minute final polymerization at 68 ° C.
  • the approximately 2.2 kb PCR product obtained was isolated, digested with Ndel and BamHI and ligated into the vector pJOE2702, which had been digested with the same restriction enzymes.
  • the E. coli strain JM109 was then transformed with the plasmid pDHE225 resulting from the ligation.
  • the gene product of the variant ftf ( ⁇ l-> 222) is shortened by 73 amino acids compared to the wild-type sequence at the N-terminus.
  • a PCR reaction was carried out with the primer ftf4 (upper) with the sequence: 5'-ATATATGTCGACGGCAGATGAAGCCAATTCAAC-3 'and the primer ftf2 (lower) ,
  • the primer ftf (upper) contains a Sall interface.
  • a purified DNA of the plasmid pDHE113 was used as template, which contains an insertion of the complete ftf gene from S. mutans DSM20523.
  • the PCR reaction was carried out as described above.
  • the approximately 2.3 kb PCR product obtained was isolated, cleaved with the Sall and BamHI restrictionases and cloned into the vector pBluescript II KS +, the shortened ftf reading frame at the 5 'end with the start region of the lacZ ⁇ contained in the vector -Reading frame was merged. On- be ⁇
  • the E. coli strain JM109 was transformed with the resulting plasmid pDHE166.
  • the fusion gene lacZ ⁇ (1— »83) :: ftf (105—» 2388) contained in the vector pDHE166 was cloned into the expression vector pJOE2702.
  • a PCR reaction with the primer ftf5 (upper) with the sequence: 5'-TATATATCATATGACCATGATTACGCCAAGC-3 'and the primer ftf2 (lower) was carried out.
  • the primer ftf5 (upper) contains an interface for the restrictase Ndel.
  • a purified DNA of the plasmid pDHE166 was used as template.
  • the PCR reaction was carried out as previously described.
  • the approximately 2.4 kb PCR product obtained was isolated, cleaved with the restrictases Ndel and BamHI and ligated into the vector pJOE2702, which had been cleaved with the same restrictases.
  • the E. coli strain JM109 was then transformed with the plasmid pDHEl71 resulting from the ligation.
  • the PCR primer ftf6 (lower) with the sequence: 5'-TTGGATCCTTATTTTTGAGAAGGTTTGACAG-3 'was used in combination with other of the primers described above.
  • the primer ftf6 (lower) contains an interface for the BamHI restrictionase.
  • the purified DNA of the plasmid pDHE113 was used as template.
  • the PCR reaction was carried out as described above.
  • the amplification product was then isolated, cleaved with the restrictionases Ndel and BamHI and ligated into the vector pJOE2702, which had previously been the same Restrictions had been split.
  • the primer combination ftf1 (upper / ftf6 (lower)
  • the plasmid pDHE132 was obtained which contains the modified ftf gene described above.
  • a PCR reaction was carried out using the DNA of the plasmid pDHE113 as template and the primers ftf3 (upper) and ftf6 (lower). After integration of the amplification product into the vector pJOE2702, the plasmid pDHE172 was obtained.
  • E. coli strains which contained one of the plasmids prepared above or the plasmid pJOE2702 for control purposes were cultivated and induced. The strains were added overnight in 5 ml dYT complete medium (Sambrook et al., Molecular Cloning: A Laboratory Manual, 2nd edition (1989), CSH Laboratory Press, Cold Spring Harbor, New York) with 100 ⁇ g ampicillin / ml 30 ° C pre-cultivated in a brooder. 50 ml of dYT medium were inoculated with the overnight culture in such a way that the optical density at 600 nm (OD 6 oo) was approximately 0.02.
  • the cells were then cultivated in Erlenmeyer flasks on an incubator shaker to an ODgoo of 0.2.
  • 0.2% (w / v) L-rhamnose was added to the medium.
  • the cells were then cultivated for a further 7 hours. After 7-hour induction, cells by centrifugation, washing, 2 P0 4 / harvested the cells in 50 mM KH K 2 HP0 4 buffer, pH 6.5, and subsequent resuspension 'of the cells in the same buffer. Thereafter, the suspension was adjusted to 6 oo _ value of 10 to an OD.
  • the cells were disrupted by ultrasound treatment or by French press treatment. All extracts were then analyzed using a.
  • Ftf activities were quantified by measuring specific Ftf activities in crude extracts. Cell cultivation, cell disruption and the preparation of the crude extracts were carried out as described above. Since each molecule of sucrose releases one molecule of glucose at each conversion, the activity was determined by determining the amount of glucose released per unit of time. The Ftf activities were determined over a period of 60 minutes at 30 ° C. using an amount of crude extract containing about 1 to 3 mU of fructosyltransferase in a volume of 1 ml with 100 mM Scr in 50 mM K 2 HP0 4 / KH 2 P0 4 buffer, pH 6.5.
  • One unit corresponds to the release of 1 micromol of glucose per 'minute in the presence of 100 mM sucrose at 30 ° C and a pH of 6.5. After an hour's incubation, the reaction was terminated by heating at 100 ° C for 10 minutes. This was followed by a .10-minute centrifugation at 10,000 x g. Subsequently, the amount of glucose released was coupled into a 100 ⁇ l aliquot using the coupled glucose oxidase (GOD) / peroxidase (POD) enzyme tests (Werner et al., Z. Analyt. Chem., 252 (1970) 224-228).
  • GOD coupled glucose oxidase
  • POD peroxidase
  • the GOD-Perid ® test (Röche Diagnostics) was used, in which the oxidation of the dye 2,2'-azino-di- (3-ethylbenzthiazoline sulfonate) (ABTS ® ) is detected photometrically.
  • the test was conducted in a total volume of 1 ml with 80 ug / ml GOD, 10 ug / ml POD, and 1 ug / ml ABTS ® in 50 mM K 2 HP0 4 / KH 2 P0 4 buffer, pH 6.5 was carried out, the absorbance at 578 nm being measured after 30 minutes.
  • the test was calibrated using standard glucose solutions. The results obtained for the crude extracts of the different expression strains are summarized in Table 1.
  • E. coli strains which have been transformed with an ftf nucleotide molecule according to the invention contained in the vector pJOE2702 show after an induction period of 6 h compared to the E. coli strain, which contains the complete ftf gene, a significantly increased cell density, ie the growth of these strains is thus significantly improved.
  • the volume yield of the expressed protein is significantly increased compared to the E. coli strain with the complete ftf gene.
  • Preculture 1 5 ml of medium (per 1000 ml of water, pH 7.0, 16 g of tryptone, 10 g of yeast extract, 5 g of NaCl and 100 mg of ampicillin) were inoculated with the strain E. coli JM109 (pDHE143) and for 12 to 15 hours incubated at 37 ° C with shaking (150 rpm).
  • Preculture 2 200 ml of the same medium were inoculated with 1 ml of preculture 1 and incubated for 12 to 15 hours at 37 ° C. with shaking.
  • Cell harvest and digestion The cells were centrifuged off with a continuous centrifuge, for example a contifuge (Heraeus) at 4 ° C. and 24300 ⁇ g. The cell mass was 1 time with 2000 ml of a 100 mM phosphate buffer, pH 6.5, washed and then resuspended in 100 ml of phosphate buffer. The cells were then disrupted in the homogenizer at 800 bar. The suspension was then centrifuged at 17360 xg for 20 minutes to separate cell debris from the enzyme present in the supernatant.
  • a contifuge Heraeus
  • Immobilization The crude extract was first freeze-dried. From the lyophilizate (about 10 g protein) pH 6.5 23.6 g in 500 ml of 1 M phosphate buffer, dissolved and, after addition of 100 EUPERGIT C ® (Röhm) G 94 hours at room temperature with shaking. The Ftf immobilizate was then washed with 50 mM phosphate buffer.
  • the separated precipitate was with 5 1 of the same isopropanol solution washed and then gently dried at 45 ° C. This gave 0.36 kg of a white product with a dry matter content (TS) of 93%. In terms of sucrose consumption, a yield of 8.5% was achieved.
  • the molecular weight of inulin, determined using the HPLC-GPC method, is 40 ⁇ 10 ⁇ g / mol, the degree of branching being 3 mol%.
  • the permeate contained 7.5 g of fructooligosaccharides, while the retentate diluted to 1 l contained 11.6 g of TS.
  • the retentate was then incubated with the endo-inulinase at a constant enzyme / substrate ratio, as previously described, after the pH had been adjusted again. This process was repeated 5 times in total.
  • Gel permeation chromatography was used in the combined permeates determined the following chain length distribution:
  • Endo-inulinase for example, SP 168; Novo
  • fructosyltransferase immobilized on Eupergit ® C (Rohm).
  • pH 6.5 50 g of immobilized fructosyl transferase (compare example 2) and 20 g of immobilized endo-inulinase were added at 30 ° C. and slowly Stir incubated. Samples were taken every hour and checked for sucrose content. As soon as sucrose was no longer detectable, the reaction was complete and the enzymes were removed from the mixture by filtration.
  • the composition of the product solution obtained was determined as follows by means of gel permeation chromatography:
  • the homooligomeric fructooligosaccharide mixtures obtained in Examples 7 and 8 with a chain length of DP 1 - DP 25 were each adjusted to a dry matter content of 10% by evaporation. 450 ml of each solution were bar in a laboratory autoclave in the presence of Raney nickel 10 hours with hydrogen at 150 and 'hy- riert 80 ° C. The solution obtained was extracted from the pumped toclaves, filtered and cleaned using an ion exchanger.
  • Cells of the strain Arthrobacter ureafaciens ATCC 21124 were divided into four shake flasks each with 100 ml of a nutrient solution containing 8 g chicory inulin (Raftiline ®), 2 g Na 2 HP0 4, 1 g KH 2 P0, 1 g NH 4 N0 3, 0 , 5 g MgS0 4 , 0.01 g Fe 2 S0 4 , 0.03 g CaS0 4 , 0.5 g yeast extract in deionized water, inoculated. A 24-hour incubation at 27 ° C. with shaking at 150 rpm was then carried out. The cells were then harvested by centrifugation and immobilized in polyvinyl alcohol gel particles.
  • a nutrient solution containing 8 g chicory inulin (Raftiline ®), 2 g Na 2 HP0 4, 1 g KH 2 P0, 1 g NH 4 N0 3, 0 , 5 g MgS0
  • immobilized fructosyltransferase (compare example 5) and 20 g of immobilized endo-inulinase and immobilized A.
  • ureafaciens cells were added to 1 l of a 10% sucrose solution, pH 6.5. Then was at 30 ° C. incubation was carried out with slow stirring. Samples were taken every hour and checked for sucrose content. As soon as sucrose was no longer detectable, the reaction was complete and the enzymes were separated from the mixture by means of filtration.

Abstract

L'invention concerne des acides nucléiques qui sont codants pour les polypeptides modifiés ayant une activité de fructosyltransférase ; des vecteurs contenant ces acides nucléiques et destinés à l'expression de la fructosyltransférase modifiée dans ces cellules procaryotes ou eucaryotes ; les cellules hôtes contenant ces vecteurs et/ou les plantes transgéniques ; un procédé de production de polyfructosanes de masses moléculaires élevées et ayant principalement des liaisons βbéta-1, 2 et un très faible taux de ramification, notamment de l'insuline ; procédé de production des fructo-oligosaccharides à l'aide de l'inuline obtenue selon l'invention ou à l'aide de saccharose, ainsi qu'un procédé de production de dianhydrides de difructose à l'aide de l'inuline obtenue selon l'invention ou à l'aide de saccharose, ainsi que l'utilisation de l'inuline obtenue selon l'invention pour produire des éthers et esters d'inuline et l'utilisation de fructo-oligosaccharides ou de fructo-oligosaccharides hydratés et de dianhydrides de difructose comme additifs alimentaires, notamment comme denrée alimentaire diététique.
EP01989498A 2000-12-21 2001-11-21 Procede de production d'hydrates de carbone Withdrawn EP1346032A2 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10063889 2000-12-21
DE10063889 2000-12-21
DE10106163 2001-02-10
DE10106163A DE10106163B4 (de) 2000-12-21 2001-02-10 Verfahren zur Herstellung von Kohlenhydraten
PCT/EP2001/013524 WO2002050257A2 (fr) 2000-12-21 2001-11-21 Procede de production d'hydrates de carbone

Publications (1)

Publication Number Publication Date
EP1346032A2 true EP1346032A2 (fr) 2003-09-24

Family

ID=26008020

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01989498A Withdrawn EP1346032A2 (fr) 2000-12-21 2001-11-21 Procede de production d'hydrates de carbone

Country Status (7)

Country Link
US (1) US20040086902A1 (fr)
EP (1) EP1346032A2 (fr)
JP (1) JP2004524826A (fr)
AU (1) AU2002227939A1 (fr)
CA (1) CA2431994A1 (fr)
MX (1) MXPA03005645A (fr)
WO (1) WO2002050257A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006118481A1 (fr) * 2005-05-04 2006-11-09 Ludan Arturo C Édulcorant de type acésulfame-k/inuline
JP5554958B2 (ja) * 2009-10-14 2014-07-23 青葉化成株式会社 野菜の軟化抑制剤、野菜の軟化抑制方法および加熱野菜
CN108642036B (zh) * 2018-05-15 2021-11-30 福建农林大学 一种镍掺杂的有序介孔氧化铝及固定化果糖基转移酶的制备方法
CN114085294B (zh) * 2021-11-18 2022-10-14 青岛农业大学 一种藏黄连多糖硒纳米粒结构表征及其活性研究方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0332108A2 (fr) * 1988-03-07 1989-09-13 Mitsubishi Kasei Corporation Procédé pour la préparation de dianhydride III de difructose
WO1996001904A1 (fr) * 1994-07-08 1996-01-25 Stichting Scheikundig Onderzoek In Nederland Production d'oligosaccharides dans des plantes transgeniques

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025542A (en) * 1992-12-28 2000-02-15 Stichting Scheikundig Onderzoek In Nederland Method for obtaining transgenic plants showing a modified fructan pattern
DE4341780A1 (de) * 1993-12-08 1995-06-14 Suedzucker Ag Hydrierte Fructooligosaccharide
ATE373094T1 (de) * 1995-01-06 2007-09-15 Plant Res Int Bv Für kohlenhydratpolymere-bildende enzyme- kodierende dna-sequenzen und verfahren zur herstellung transgener pflanzen
DE19617687C2 (de) * 1996-05-03 2000-11-16 Suedzucker Ag Verfahren zur Herstellung transgener, Inulin erzeugender Pflanzen
DE19749122A1 (de) * 1997-11-06 1999-06-10 Max Planck Gesellschaft Nucleinsäuremoleküle codierend Enzyme, die Fructosyltransferaseaktivität besitzen
DE19840028A1 (de) * 1998-09-02 2000-03-09 Max Planck Gesellschaft Nucleinsäuremoleküle codierend Enzyme, die Fructosyltransferaseaktivität besitzen, und deren Verwendung

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0332108A2 (fr) * 1988-03-07 1989-09-13 Mitsubishi Kasei Corporation Procédé pour la préparation de dianhydride III de difructose
WO1996001904A1 (fr) * 1994-07-08 1996-01-25 Stichting Scheikundig Onderzoek In Nederland Production d'oligosaccharides dans des plantes transgeniques

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
EBISU S ET AL: "Structural differences in fructans elaborated by Streptococcus mutans and Strep. salivarius", JOURNAL OF BIOCHEMISTRY, vol. 78, no. 5, 1975, pages 879 - 887, XP008067870, ISSN: 0021-924X *
KANG S ET AL.: "Purification and properties of an endo-inulinase from Arthrobacter sp.", BIOTECHNOLOGY LETTERS, vol. 20, no. 10, October 1998 (1998-10-01), pages 983 - 986 *
KIM DONG HYUN ET AL: "Production of inulo-oligosaccharides using endo-inulinase from a Pseudomonas sp.", BIOTECHNOLOGY LETTERS, vol. 19, no. 4, 1997, pages 369 - 371, ISSN: 0141-5492 *
MENNE E ET AL: "Fn-type chicory inulin hydrolysate has a prebiotic effect in humans", THE JOURNAL OF NUTRITION, vol. 130, no. 5, May 2000 (2000-05-01), pages 1197 - 1199, XP002194170 *
NAHN A N ET AL.: "Immunization with dextransucrases, levansucrases and glycosidic hydrolases from oral streptococci. II. Immunization with glucosyltransferases, fructosyltransferases and glycosidic hydrolases from oral Streptococci in monkeys.", JOURNAL OF DENTAL RESEARCH, vol. 56, no. 12, December 1977 (1977-12-01), pages 1586 - 1598 *

Also Published As

Publication number Publication date
WO2002050257A2 (fr) 2002-06-27
US20040086902A1 (en) 2004-05-06
MXPA03005645A (es) 2004-04-21
JP2004524826A (ja) 2004-08-19
AU2002227939A1 (en) 2002-07-01
CA2431994A1 (fr) 2002-06-27
WO2002050257A3 (fr) 2003-01-30

Similar Documents

Publication Publication Date Title
DE69535543T2 (de) Für enzyme, die die fähigkeit besitzen lineare alpha 1,4-glucane in pflanzen, pilzen und mikroorganismen zu synthesieren, kodierende dna sequenzen
DE60037191T2 (de) Genetisch modifizierte pflanzenzellen und pflanzen mit einer erhöhten aktivität eines amylosucrase-proteins und eines verzweigungsenzyms
EP1117802B1 (fr) Molecules d'acide nucleique codant une enzyme de ramification de bacteries du genre neisseria et procede pour produire des alpha-1,4 glucanes ramifiees en alpha-1,6
KR20090010024A (ko) 유전자 조작법에 의한 덱스트란수크라제 ｄｓｒ－ｓ의 신규변이체의 제조
DE69534685T2 (de) Transferase und amylase, verfahren zur herstellung dieser enzyme, ihre verwendung und für die kodierende gene
US11859216B2 (en) Compositions and methods comprising the use of a Bacillus agaradhaerens inulosucrase (INUO)
DE60024271T2 (de) Expression von stärke-bindenden domänen und/oder von stärke-bindende domänen enthaltenden fusionsproteinen in pflanzen
DE69532485T2 (de) Trehalose-freisetzendes Enzym, dafür kodierende DNA, Herstellung und Verwendung
DE60035801T2 (de) Bakterielle stämme von genus klebsiella und deren gen kodierend für isomaltulose synthase
DE69738085T2 (de) Modifikation von polysacchariden
CN112004939A (zh) 用磷酸化酶合成包含β-1,3糖苷键的葡聚糖
EP1108037B1 (fr) Enzymes codant des molecules d'acide nucleique et ayant une activite de transferase du fructosyle, et utilisation de ces enzymes
US6635460B1 (en) Fructosyltransferases
EP1346032A2 (fr) Procede de production d'hydrates de carbone
DE10106163B4 (de) Verfahren zur Herstellung von Kohlenhydraten
WO1995032279A1 (fr) Bacterie produisant de la cellulose, obtenue par une transformation par un gene codant pour un enzyme implique dans le metabolisme du saccharose
DE102007041861A1 (de) Herstellung von Polymeren mit reduziertem Acylgehalt
JP4012931B2 (ja) 非還元性糖質生成酵素及びトレハロース遊離酵素ならびに該酵素を用いる糖質の製造方法
US7495152B2 (en) Identification and characterization of a novel alpha-amylase from maize endosperm
KR101412717B1 (ko) 스트렙토마이세스 시리칼라의 자일로글루카네이즈
JP2009153516A (ja) β−Ｌ−アラビノピラノシダーゼ
JP4012932B2 (ja) 非還元性糖質生成酵素及びトレハロース遊離酵素ならびに該酵素を用いる糖質の製造方法
Baciu Extracted sugar-beet pulp and sucrose, two renewable materials as" hot" substrates for enzymatic synthesis of valuable saccharides
Lee et al. Production and application of functional bacterial cellulose
Olvera et al. 26. Agroindustrial synthesis of fructans from sucrose

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030730

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MATTES, RALF

Inventor name: VOGEL, MANFRED

Inventor name: MUNIR, MOHAMMAD

Inventor name: KUNZ, MARKWART

Inventor name: HAJI BEGLI, ALIREZA

Inventor name: ENGELS, DIRK

17Q First examination report despatched

Effective date: 20060825

17Q First examination report despatched

Effective date: 20060825

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071010